Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-16

Clinical Trial Update: Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating intranasal naloxone to reduce gambling urges and craving in gambling disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone intranasal (Naloxone)

Snippet

Sponsor: Finnish Institute for Health and Welfare | Conditions: Pathological Gambling, Gambling Disorder | Phase 2 | Status: UNKNOWN